skip to Main Content

Good news from IRBM RAI TGR Lazio – 18th Marc

ENGLISH TRANSCRIPT

TGR LAZIO PRESENTER:

And the race is now on to test a vaccine on animals, it’s just the first step. Good news on this has come from the same company in Pomezia which, 5 years ago, developed the vaccine for Ebola. Let’s hear about it from Maria Luigia De Stefano.

MARIA LUIGIA DE STEFANO:

The war against Coronavirus is also being fought in the laboratory: researchers, scientists from all over the world are working to come up with a vaccine. A step forward in this direction has come from Pomezia, from the same company that in 2015 developed the vaccine for Ebola and produced over a million doses. After close collaboration with the University of Oxford it is now ready for testing.

PIERO DI LORENZO:

As early as the end of May we’ll have enough doses to test it on mice, we think that a month will be needed to do the tests on mice, so by the end of June, early July, we can start testing it on humans.

MARIA LUIGIA DI STEFANO:                                                                       

For human testing, health protocols require 3 phases, with an increasing number of people involved, but whereas phase 1 only takes a few months, phases 2 and 3 could take years.

PIERO DI LORENZO:

All of the timescales for phases 2 and 3 can be reduced by the national and international regulatory authorities should they feel there is a need to intervene quickly in the event of the pandemic becoming even more dangerous.

MARIA LUIGIA DI STEFANO:

While awaiting the first batch of vaccine, in Pomezia they continue to work tirelessly. Good results have also been achieved in America and Israel. The researchers explain to us that the important thing in this competition is to get there, not to get there first.

PIERO DI LORENZO:

We have to hope that it comes quickly for the people already working on it. I am reasonably optimistic that we may reach the conclusion within a fairly acceptable timescale.

Back To Top